Procyon Advisors, LLC Amgen Inc Transaction History

Procyon Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Procyon Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Procyon Advisors, LLC holds 9,363 shares of AMGN stock, worth $2.48 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

9,363

Previous 10,215 8.34%

Holding current value

$2.48 Million

Previous $3.19 Million 5.48%

% of portfolio

0.21%

Previous 0.24%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$309.38 - $337.38 $263,591 - $287,447	-852 Reduced 8.34%	9,363 $3.02 Million
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $270,107 - $328,250	-1,028 Reduced 9.14%	10,215 $3.19 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $23,391 - $28,236	87 Added 0.78%	11,243 $3.2 Million
Q4 2023 Jan 18, 2024	SELL	$255.7 - $288.46 $168,506 - $190,095	-659 Reduced 5.58%	11,156 $3.21 Million
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $281,621 - $349,640	1,288 Added 12.24%	11,815 $3.18 Million
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $484,035 - $572,362	2,259 Added 27.32%	10,527 $2.34 Million
Q1 2023 Apr 10, 2023	BUY	$225.79 - $275.2 $265,980 - $324,185	1,178 Added 16.61%	8,268 $2 Million
Q4 2022 Jan 19, 2023	BUY	$229.03 - $291.01 $120,927 - $153,653	528 Added 8.05%	7,090 $0
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $142,083 - $160,243	633 Added 10.68%	6,562 $1.48 Million
Q2 2022 Jul 11, 2022	BUY	$230.71 - $256.74 $16,149 - $17,971	70 Added 1.19%	5,929 $1.44 Million
Q1 2022 Apr 18, 2022	BUY	$219.27 - $242.57 $10,744 - $11,885	49 Added 0.84%	5,859 $1.42 Million
Q4 2021 Jan 18, 2022	BUY	$198.88 - $227.6 $182,571 - $208,936	918 Added 18.77%	5,810 $1.31 Million
Q3 2021 Oct 14, 2021	BUY	$212.27 - $248.7 $746,553 - $874,677	3,517 Added 255.78%	4,892 $1.04 Million
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $29,431 - $32,651	126 Added 10.09%	1,375 $335,000
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $24,188 - $28,187	109 Added 9.56%	1,249 $311,000
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $3,462 - $4,122	16 Added 1.42%	1,140 $262,000
Q3 2020 Oct 22, 2020	BUY	$234.65 - $260.95 $30,739 - $34,184	131 Added 13.19%	1,124 $286,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $85,651 - $105,106	433 Added 77.32%	993 $234,000
Q4 2019 Feb 21, 2020	BUY	$189.21 - $243.2 $105,957 - $136,192	560 New	560 $135,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Account

Procyon Advisors, LLC Amgen Inc Transaction History